BIT 5.00% 1.9¢ biotron limited

victrelis approved in austr, page-5

  1. 765 Posts.
    rgc68 pricing is going to have a significant impact on what treatments are used,especially in the developing markets of Asia and South America.


    Does anyone know the price comparisons re...rib/int....victrelis...and the other new options?



    Also if HIV is where it happens for BIT225,so be it.As long as they can build on the positives of the last few months?
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.